Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil pharmacokinetics, pharmacogenomics, and anaesthesia monitor effects in children
2015-000051-24Phase 4Completed
- Sponsor
- Klaus Olkkola/University of Helsinki
- Start
- Jan 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remifentanil, sponsored by Klaus Olkkola/University of Helsinki. Primary endpoint: Completion of planned surgical pleth index and entropy measurements. Started Jan 2015; status: completed.
02
Drugs
remifentanil
Beyond the preview
Go deeper on 2015-000051-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000051-24.